Molecular Dynamics of CYP2D6 Polymorphisms in the Absence and Presence of a Mechanism-Based Inactivator Reveals Changes in Local Flexibility and Dominant Substrate Access Channels-Reference-Cited by-同舟云学术

Molecular Dynamics of CYP2D6 Polymorphisms in the Absence and Presence of a Mechanism-Based Inactivator Reveals Changes in Local Flexibility and Dominant Substrate Access Channels

Published:2014-10-06 Issue:10 Volume:9 Page:e108607
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

de Waal Parker W.,Sunden Kyle F.,Furge Laura Lowe

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. Cytochromes P450, drugs, and diseases;FP Guengerich;Mol Interv,2003

2. Predicting in vivo drug interactions from in vitro drug discovery data;LC Wienkers;Nat Rev Drug Discov,2005

3. New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme;B Wang;Drug Metab Rev,2009

4. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity;M Ingelman-Sundberg;Pharmacogenomics J,2005

5. Comparison of cytochrome P450 2D6 and variants in terms of drug oxidation rates and substrate inhibition;T Niwa;Curr Drug Metab,2011

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging in Vitro Models for Clinically Relevant RareCYP2D6Variants in Pharmacogenomics;Drug Metabolism and Disposition;2024-01-02

2. Whole blood hydroxychloroquine: Does genetic polymorphism of cytochrome P450 enzymes have a role?;Clinical and Experimental Medicine;2023-07-22

3. Computer-Aided (In Silico) Modeling of Cytochrome P450-Mediated Food–Drug Interactions (FDI);International Journal of Molecular Sciences;2022-07-31

4. A Computational Understanding of Inter-Individual Variability in CYP2D6 Activity to Investigate the Impact of Missense Mutations on Ochratoxin A Metabolism;Toxins;2022-03-14

5. Role of P34S, G169R, R296C, and S486T Substitutions in Ligand Access and Catalysis for Cytochrome P450 2D6 Allelic Variants CYP2D6*14A and CYP2D6*14B;Drug Metabolism and Bioanalysis Letters;2022-03